The primary endpoint of the study , the @-year patency rate of the SV composite grafts , was @ % ( @ of @ ) and was noninferior to that of the RITA composite grafts ( @ % -LSB- @ of @ -RSB- ) with a @ % lower confidence limit of -@ % ( P < @ for noninferiority ) .